Global Q Fever Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 96

Report ID: 6569

Q fever is a mild disease with flu-like symptoms. Many patients have no symptoms at all while in some cases; the infection can reoccur/resurface years later. The chronic Q fever is a more deadly form of Q fever which may damage heart, liver, brain, lungs and can cause diabetes in some cases.
The Americas account for the largest share in the global Q fever market owing to the presence of key players in the market and rising emphasis on diagnosis and treatment of rare diseases. Furthermore, the rising awareness about bacterial infection further accelerates the growth of the market. North America is the accounted for the highest market share in this region with the U.S. being the largest market followed by Canada. In the U.S, the prevalence of cardiovascular disease is found to be increasing from last few years. This is attributed to the rising prevalence of chronic diseases such as obesity and diabetes which are major risk factors for cardiovascular diseases.

The global Q Fever market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Q Fever volume and value at global level, regional level and company level. From a global perspective, this report represents overall Q Fever market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Yashica Pharmaceuticals Private Limited (India)
Merck & Co. (U.S.)
Atox Bio (Israel)
Teva Pharmaceutical Industries (Israel)
Basilea Pharmaceutica Ltd. (Switzerland)
MELINTA THERAPEUTICS, INC. (U.S.)
Pfizer (U.S.)
Cipla Inc. (India)

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Acute Q Fever
Chronic Q Fever

Segment by Application
Hospitals & Clinics
Diagnostic Centers
Surgical Centers

Table of Contents

Executive Summary
1 Q Fever Market Overview
1.1 Product Overview and Scope of Q Fever
1.2 Q Fever Segment by Type
1.2.1 Global Q Fever Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Acute Q Fever
1.2.3 Chronic Q Fever
1.3 Q Fever Segment by Application
1.3.1 Q Fever Consumption Comparison by Application (2014-2025)
1.3.2 Hospitals & Clinics
1.3.3 Diagnostic Centers
1.3.4 Surgical Centers
1.4 Global Q Fever Market by Region
1.4.1 Global Q Fever Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Q Fever Market Size
1.5.1 Global Q Fever Revenue (2014-2025)
1.5.2 Global Q Fever Production (2014-2025)

2 Global Q Fever Market Competition by Manufacturers
2.1 Global Q Fever Production Market Share by Manufacturers (2014-2019)
2.2 Global Q Fever Revenue Share by Manufacturers (2014-2019)
2.3 Global Q Fever Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Q Fever Production Sites, Area Served, Product Types
2.5 Q Fever Market Competitive Situation and Trends
2.5.1 Q Fever Market Concentration Rate
2.5.2 Q Fever Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Q Fever Production Market Share by Regions
3.1 Global Q Fever Production Market Share by Regions
3.2 Global Q Fever Revenue Market Share by Regions (2014-2019)
3.3 Global Q Fever Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Q Fever Production
3.4.1 North America Q Fever Production Growth Rate (2014-2019)
3.4.2 North America Q Fever Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Q Fever Production
3.5.1 Europe Q Fever Production Growth Rate (2014-2019)
3.5.2 Europe Q Fever Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Q Fever Production (2014-2019)
3.6.1 China Q Fever Production Growth Rate (2014-2019)
3.6.2 China Q Fever Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Q Fever Production (2014-2019)
3.7.1 Japan Q Fever Production Growth Rate (2014-2019)
3.7.2 Japan Q Fever Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Q Fever Consumption by Regions
4.1 Global Q Fever Consumption by Regions
4.2 North America Q Fever Consumption (2014-2019)
4.3 Europe Q Fever Consumption (2014-2019)
4.4 China Q Fever Consumption (2014-2019)
4.5 Japan Q Fever Consumption (2014-2019)

5 Global Q Fever Production, Revenue, Price Trend by Type
5.1 Global Q Fever Production Market Share by Type (2014-2019)
5.2 Global Q Fever Revenue Market Share by Type (2014-2019)
5.3 Global Q Fever Price by Type (2014-2019)
5.4 Global Q Fever Production Growth by Type (2014-2019)

6 Global Q Fever Market Analysis by Applications
6.1 Global Q Fever Consumption Market Share by Application (2014-2019)
6.2 Global Q Fever Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Q Fever Business
7.1 Yashica Pharmaceuticals Private Limited (India)
7.1.1 Yashica Pharmaceuticals Private Limited (India) Q Fever Production Sites and Area Served
7.1.2 Q Fever Product Introduction, Application and Specification
7.1.3 Yashica Pharmaceuticals Private Limited (India) Q Fever Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Merck & Co. (U.S.)
7.2.1 Merck & Co. (U.S.) Q Fever Production Sites and Area Served
7.2.2 Q Fever Product Introduction, Application and Specification
7.2.3 Merck & Co. (U.S.) Q Fever Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Atox Bio (Israel)
7.3.1 Atox Bio (Israel) Q Fever Production Sites and Area Served
7.3.2 Q Fever Product Introduction, Application and Specification
7.3.3 Atox Bio (Israel) Q Fever Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Teva Pharmaceutical Industries (Israel)
7.4.1 Teva Pharmaceutical Industries (Israel) Q Fever Production Sites and Area Served
7.4.2 Q Fever Product Introduction, Application and Specification
7.4.3 Teva Pharmaceutical Industries (Israel) Q Fever Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Basilea Pharmaceutica Ltd. (Switzerland)
7.5.1 Basilea Pharmaceutica Ltd. (Switzerland) Q Fever Production Sites and Area Served
7.5.2 Q Fever Product Introduction, Application and Specification
7.5.3 Basilea Pharmaceutica Ltd. (Switzerland) Q Fever Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 MELINTA THERAPEUTICS, INC. (U.S.)
7.6.1 MELINTA THERAPEUTICS, INC. (U.S.) Q Fever Production Sites and Area Served
7.6.2 Q Fever Product Introduction, Application and Specification
7.6.3 MELINTA THERAPEUTICS, INC. (U.S.) Q Fever Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Pfizer (U.S.)
7.7.1 Pfizer (U.S.) Q Fever Production Sites and Area Served
7.7.2 Q Fever Product Introduction, Application and Specification
7.7.3 Pfizer (U.S.) Q Fever Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Cipla Inc. (India)
7.8.1 Cipla Inc. (India) Q Fever Production Sites and Area Served
7.8.2 Q Fever Product Introduction, Application and Specification
7.8.3 Cipla Inc. (India) Q Fever Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served

8 Q Fever Manufacturing Cost Analysis
8.1 Q Fever Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Q Fever
8.4 Q Fever Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Q Fever Distributors List
9.3 Q Fever Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Q Fever Market Forecast
11.1 Global Q Fever Production, Revenue Forecast
11.1.1 Global Q Fever Production Growth Rate Forecast (2019-2025)
11.1.2 Global Q Fever Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Q Fever Price and Trend Forecast (2019-2025)
11.2 Global Q Fever Production Forecast by Regions (2019-2025)
11.2.1 North America Q Fever Production, Revenue Forecast (2019-2025)
11.2.2 Europe Q Fever Production, Revenue Forecast (2019-2025)
11.2.3 China Q Fever Production, Revenue Forecast (2019-2025)
11.2.4 Japan Q Fever Production, Revenue Forecast (2019-2025)
11.3 Global Q Fever Consumption Forecast by Regions (2019-2025)
11.3.1 North America Q Fever Consumption Forecast (2019-2025)
11.3.2 Europe Q Fever Consumption Forecast (2019-2025)
11.3.3 China Q Fever Consumption Forecast (2019-2025)
11.3.4 Japan Q Fever Consumption Forecast (2019-2025)
11.4 Global Q Fever Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Q Fever Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer